Union Health and Family Welfare Minister J.P. Nadda has been
More than 950 delegates, including infectious disease specialists, clinicians, researchers,
PIL in Delhi High Court Seeks Immediate Operationalisation of ₹400-Crore Super Speciality Block at RML Hospital
A Public Interest Litigation (PIL) has been filed before the Delhi High Court seeking the immediate operationalisation of the ₹400-crore Super Speciality Block at
Centre Plans Nationwide Fitness Drive as Lifestyle Diseases Surge Across India
The Central Government is preparing to launch a nationwide fitness and preventive healthcare campaign to tackle the rising burden of non communicable diseases (NCDs),
Kerala’s 50-Day Health Report Highlights Hospital Expansion, AIIMS Proposal and CSR-Backed Infrastructure Drive
The Kerala Government has released its Health Department Report Card for the first 50 days of the new administration, outlining key initiatives aimed at
Oxford University Launches First Human Trial of Bundibugyo Ebola Vaccine Press Release
The University of Oxford has launched the first human clinical trial of a vaccine targeting the Bundibugyo strain of the Ebola virus, marking a
CBM India Champions the Dialogue on Disability-Inclusive Eye Health at VISION 2020: The Right to Sight – INDIA Conference
Sessions and panels make the case for eye health systems designed for persons with disabilities from the outset, with services free of barriers As India
Aakash Healthcare Crosses 10,000 Deliveries, Says One in Four Pregnancies Were ‘High-Risk’ Rising High-Risk Pregnancies Reflect Need for Multi-Disciplinary, Integrated Care
Aakash Healthcare has achieved the milestone of 10,000 deliveries since the launch of its maternity services in 2017, with doctors saying the achievement reflects
Cancer Patient Dies After Drug Access Plea Was Listed 57 Times, Experts Seek Faster Hearings in Life-Saving Medicine Cases
A cancer patient seeking access to a life-saving medicine has died after her petition was reportedly listed for hearing 57 times without a final
US FDA Approves At-Home Starter Dose of Eisai-Biogen Alzheimer’s Drug Leqembi
The U.S. Food and Drug Administration (FDA) has approved an at-home starter dose for Leqembi (lecanemab), the Alzheimer's disease therapy jointly developed by Eisai
